258 related articles for article (PubMed ID: 34078437)
1. Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology.
Zai X; Yin Y; Guo F; Yang Q; Li R; Li Y; Zhang J; Xu J; Chen W
Vet Res; 2021 Jun; 52(1):75. PubMed ID: 34078437
[TBL] [Abstract][Full Text] [Related]
2. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
[TBL] [Abstract][Full Text] [Related]
3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
5. Identification of Cross-Protective Potential Antigens against Pathogenic
Hisham Y; Ashhab Y
J Immunol Res; 2018; 2018():1474517. PubMed ID: 30622973
[TBL] [Abstract][Full Text] [Related]
6. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
[TBL] [Abstract][Full Text] [Related]
7. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
8. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
[TBL] [Abstract][Full Text] [Related]
9. Essential role of vaccines in brucellosis control and eradication programs for livestock.
Olsen SC; Stoffregen WS
Expert Rev Vaccines; 2005 Dec; 4(6):915-28. PubMed ID: 16372886
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Based Vaccine of a
Oliveira KC; Brancaglion GA; Santos NCM; Araújo LP; Novaes E; Santos RL; Oliveira SC; Corsetti PP; de Almeida LA
Front Immunol; 2021; 12():778475. PubMed ID: 34992597
[No Abstract] [Full Text] [Related]
12. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
[TBL] [Abstract][Full Text] [Related]
13. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
Senevirathne A; Hewawaduge C; Lee JH
Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
[TBL] [Abstract][Full Text] [Related]
14. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
[TBL] [Abstract][Full Text] [Related]
15. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
17. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
[TBL] [Abstract][Full Text] [Related]
18. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
19. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
[TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
